Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Revenue
Evolus had revenue of $68.97M USD in the quarter ending September 30, 2025, with 12.90% growth. This brings the company's revenue in the last twelve months to $285.82M, up 15.10% year-over-year. In the year 2024, Evolus had annual revenue of $266.27M with 31.76% growth.
Revenue (ttm)
$285.82M
Revenue Growth
+15.10%
P/S Ratio
0.96
Revenue / Employee
$868.76K
Employees
329
Market Cap
203.66M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 266.27M | 64.19M | 31.76% |
| Dec 31, 2023 | 202.09M | 53.47M | 35.98% |
| Dec 31, 2022 | 148.62M | 48.94M | 49.10% |
| Dec 31, 2021 | 99.67M | 43.13M | 76.29% |
| Dec 31, 2020 | 56.54M | 21.62M | 61.89% |
| Dec 31, 2019 | 34.93M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Integrated Diagnostics Holdings | 114.96M |
| Optima Health | 113.75M |
| Animalcare Group | 81.07M |
| Tristel | 46.46M |
Evolus News
- 4 weeks ago - Stifel Analyst Lowers Price Target on Evolus (EOLS) to $17.00 | EOLS Stock News - GuruFocus
- 4 weeks ago - Evolus (EOLS) Achieves Sixth Year of Double-Digit Growth in 2025 - GuruFocus
- 4 weeks ago - Evolus (EOLS) Projects Strong Revenue Growth Through 2028 - GuruFocus
- 4 weeks ago - Evolus sees Q4 net revenue between $88.6M and $90.6M - Seeking Alpha
- 4 weeks ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire
- 7 weeks ago - Needham Reiterates Hold Rating for Evolus (EOLS) | EOLS Stock News - GuruFocus
- 2 months ago - Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 - Seeking Alpha
- 2 months ago - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings - Seeking Alpha